Immuneering Corporation (IMRX) Technical Analysis

🔺 Technical Setup

🎯 Decision Map

From a roadmap perspective, the setup is boxed by support near 5.11 and resistance around 5.42. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis. Pattern invalidation sits near 7.80, so a violation there would materially change the current setup narrative.

📊 Technical Summary

Immuneering Corporation (IMRX) finished the session at 5.24 (-0.19%). With price below both the 50-day and 200-day moving averages, the broader structure still reflects elevated technical pressure. 20-day momentum is running at -1.69%, with price remains inside its roughly 52-week range (1.10–9.26), while ATR14 volatility is elevated at roughly 7.50% of price. RSI(14) is 44.7, leaving momentum in a fairly neutral range. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram is negative and weakening further, which reflects continued downside pressure. The most important nearby levels are support at 5.11 and resistance at 5.42. Clearing resistance would improve continuation odds, while slipping below support would weaken the present setup. On the fundamentals side, the latest snapshot shows Net income: -14.96M · EPS (basic): -0.38. For a fuller technical read, the interactive view adds overlays, pattern context and broader chart structure.

Explore more